The Vision Thief

DEC. 15, 2017
Glaucoma is the leading cause of irreversible blindness throughout the world. Read about the Lasker/IRRF initiative aiming to accelerate discovery of novel ways to treat and prevent this condition.

In Utero Gene Therapy

DEC. 4, 2017
Lasker Laureate Yuet Wai Kan discusses major challenges in the development of novel therapies employing stem cells for the treatment of sickle cell disease and thalassemia.

The Inventor of the Pap Test

DEC. 4, 2017
Follow Lasker Laureate George Papanicolaou's path from studying music and humanities to developing a diagnostic method for detecting cervical cancer.

Fall 2017 Newsletter

2017 Fall
From the development of the Pap smear in the 1940s to new non-invasive prenatal testing techniques, Lasker Laureates have played an important role in improving diagnostic technology, sometimes unexpectedly. Read an interview with leading scientists from academia, industry, and government on new developments, and learn about historic milestones that have changed the way diseases are diagnosed and treated.

International Medicine and Global Health

DEC. 1, 2017
The November 30, 2017 Lasker Lessons in Leadership lecture was given by Anne Schuchat, Principal Deputy Director at the Centers for Disease Control and Prevention, and a Rear Admiral of the U.S. Public Health Service.

Paul Turner: The Good, the Bad, and the Ugly of Viruses

OCT. 26, 2017
Public Lecture. Are viruses alive? How, when, and why do viruses jump to new species and what are the implications for human health? Can viruses be harnessed as cures for dangerous bacterial infections and other diseases? A talk by Paul Turner, a professor of ecology and evolutionary biology at Yale University.

2017 Young Scientist Seminars: Meet the Winners

OCT. 6, 2017
The Young Scientist Seminars (YSS) nurture science communication skills of talented PhD students and postdocs. The Lasker Foundation is proud to sponsor the annual YSS competition with iBiology and the Alan Alda Center for Communicating Science.

Go to Top